Innovent Biologics Inc. held its annual general meeting on June 25, 2025. During the meeting, a proposal to extend the general mandate granted to the Directors to issue shares by adding the total number of shares to be bought back was approved. Additionally, the grant of 2,754,000 restricted shares to Dr. De-Chao Michael Yu was also approved.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.